Abstract: Described herein are embodiments of methods, devices and computer program products for tamper detection in a meter. One aspect of the method includes using a magnetic field strength sensor to continuously detect magnetic field strength proximate to a meter. In one aspect, the magnetic field strength sensor produces an analog voltage signal proportional to the detected magnetic field strength. The analog voltage signal of the sensor is continuously converted to a digital voltage signal. The digital voltage signal is stored in a memory at timed intervals, and the digital voltage signal is monitored for an aberration that indicates tampering of the meter. If tampering is detected, then an alarm is triggered to indicate the tampering.

Abstract: Described herein are embodiments of methods, devices and computer program products for tamper detection in a meter. One aspect of the method comprises using a magnetic field strength sensor to continuously detect magnetic field strength proximate to a meter. In one aspect, the magnetic field strength sensor produces an analog voltage signal proportional to the detected magnetic field strength. The analog voltage signal of the sensor is continuously converted to a digital voltage signal. The digital voltage signal is stored in a memory on an intermittent basis, and the digital voltage signal is monitored for an aberration that indicates tampering of the meter. If tampering is detected, then an alarm is triggered to indicate the tampering.

Abstract: The invention comprises an anti-idiotypic antibody designated 2F10 and permitted variants thereof, which have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial but not complete homology with such surface antigen. The invention further comprises a peptide having a chain comprising the amino acid residues Ala Val Tyr Tyr Cys Thr Arg Gly Tyr His Gly Ser Ser Leu Tyr and permitted variants thereof, which, like 2F10, have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial, but not complete, homology with said surface antigen. The amino acid sequence is found in and forms a part of 2F10.

Abstract: The invention comprises an anti-idiotypic antibody designated 2F10 and permitted variants thereof, which have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial but not complete homology with such surface antigen. The invention further comprises a peptide having a chain comprising the amino acid residues Ala Val Tyr Tyr Cys Thr Arg Gly Tyr His Gly Ser Ser Leu Tyr and permited variants thereof, which, like 2F10, have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial, but not complete, homology with said surface antigen. The amino acid sequence is found in and forms a part of 2F10.

Abstract: The invention comprises an anti-idiotypic antibody designated 2F10 and permitted variants thereof, which have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial but not complete homology with such surface antigen. The invention further comprises a peptide having a chain comprising the amino acid residues Ala Val Tyr Tyr Cys Thr Arg Gly Tyr His Gly Ser Ser Leu Tyr and permited variants thereof, which, like 2F10, have antigenic properties similar to the group specific "a" determinant of human hepatitis B surface antigen HBsAg and have at least partial, but not complete, homology with said surface antigen. The amino acid sequence is found in and forms a part of 2F10.